x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The IMID Forum

The Immune-Mediated Inflammatory Disease Forum

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

education

All Episodes

00:40:11

Insights at ACR 2021: Basic Science / Beyond RA

The IMID Forum ·

2021/12/14

Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.

en

00:48:07

Insights at ACR 2021: PROs and JAK Treatment

The IMID Forum ·

2021/12/13

Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.

en

00:47:06

Insights at ACR 2021: Clinical Outcomes in RA

The IMID Forum ·

2021/12/12

Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.

en

00:30:06

Insights at ACR 2021: JAKs in Spondyloarthritis

The IMID Forum ·

2021/12/11

Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.

en

00:31:49

Insights at ACR 2021: COVID-19 Vaccination and Rituximab

The IMID Forum ·

2021/12/10

Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.

en

00:39:22

Insights at ACR 2021: Impact of COVID-19 on Practice

The IMID Forum ·

2021/12/09

Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.

en

00:40:04

Insights at ACR 2021: COVID Vaccinations

The IMID Forum ·

2021/12/07

Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.

en

00:24:20

Author Interview: Professor Atul Deodhar

The IMID Forum ·

2021/12/06

Professor Atul Deodhar, professor of medicine at Oregon Health & Science University. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Atul Deodhar discusses his review on JAK-STAT signalling in spondyloarthritis and what that means for the use of JAK inhibitors for SpA treatment.

en

00:08:25

Discussing Rheumatology: Risk of HZ with UPA, and...

The IMID Forum ·

2021/12/06

Prof Iain McInnes reviews two papers this month, and discusses the increased risk of HZ infection with upadacitinib, as well as the role of the JAK-STAT pathway in SpA pathenogenesis. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

en

00:28:54

Author Interview: Professor Roy Fleischmann

The IMID Forum ·

2021/11/18

Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Roy Fleishmann discusses the effect of baricitinib on inhibiting radiographic progression of structural joint damage over 5 years in patients with active RA.

en

00:26:04

ACR 2021: Day 4 Highlights

The IMID Forum ·

2021/11/09

Grace Wright presents the Day 4 highlights of the key abstracts and posters presented at ACR 2021.

en

00:21:50

ACR 2021: Day 3 Highlights

The IMID Forum ·

2021/11/08

Professor Leonard Calabrese presents the Day 3 highlights of the key abstracts and posters presented at ACR 2021.

en

00:23:06

ACR 2021: Day 2 Highlights

The IMID Forum ·

2021/11/07

Grace Wright presents the Day 2 highlights of the key abstracts and posters presented at ACR 2021.

en

00:07:56

Discussing Rheumatology: Herpes Zoster and HBV

The IMID Forum ·

2021/11/04

Prof Iain McInnes discusses the risk of herpes zoster in RA patients taking biologics and DMARDS. He also discusses reactivation of hepatitis B in patients with RA taking tofacitinib. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

en

00:10:49

ACR 2021: Day 1 Highlights

The IMID Forum ·

2021/11/04

Prof Calabrese presents the Day 1 highlights of the key abstracts and posters presented at ACR 2021.

en

00:13:14

ACR 2021 Preview Podcast

The IMID Forum ·

2021/11/04

A preview of the latest research at ACR 2021. Prof Ritchlin highlights important abstracts in cytokine signalling at the upcoming ACR Convergence.

en

00:19:38

Rheumatology Author Professor Paul Bird: Tofacitinib...

The IMID Forum ·

2021/10/14

Paul Bird, Conjoint Professor at the University of South Wales. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Paul Bird assess the real‑world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia.

en

00:08:12

Discussing Rheumatology: Poor Prognostic Factors,...

The IMID Forum ·

2021/09/23

Prof Iain McInnes discusses poor prognostics factors from the FINCH 3 study, and the effectiveness and persistence of monotherapy and combination therapy from the Australian OPAL study. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

en

00:28:57

Rheumatology Author Professor Kurt de Vlam: Pain...

The IMID Forum ·

2021/09/10

Kurt de Vlam, Professor of Rheumatology at UZ Leuven, Belgium. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor de Vlam assess the impact of baseline pain severity on pain response and the time to improvement in patients with PsA receiving tofacitinib.

en

00:25:15

Rheumatology Author Professor Strand: Upadacitinib...

The IMID Forum ·

2021/09/09

Vibeke Strand, Adjunct Clinical Professor in the Division of Immunology/Rheumatology, Biopharmaceutical Consultant at Stanford University School of Medicine. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Strand discusses improvements in PROs in patients with RA treated with upadacitinib monotherapy.

en

388 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College